| ²é¿´: 977 | »Ø¸´: 15 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
cxmlxmf123Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
|
[ÇóÖú]
¼±£ºÓÐÈýƪ²Î¿¼ÎÄÏ×ÐèÒªÎÄÕÂÃû
|
|
|
¼±£ºÐֵܽãÃÃÃǺã¬ÎÒһƪÎÄÕÂÒò¸ÄͶһ¸öÆÚ¿¯£¬ÓÐÈýƪ²Î¿¼ÎÄÏ×ÕÒ²»µ½ÎÄÕÂÆªÃû£¬Çë¸Ï¿ì°ïÎÒ£¬·îÏ×20½ð±Ò×öΪ³êл£¡ 1¡¢S. Q. Xie, G. Q. Hu, Z. Q. Zhang, M. Xu, B. S. Ji, J. Pharm. Pharmacol., 2008, 60, 213. 2¡¢K. D. Patel, B. D. Mistry, K. R. Desai, Orient J. Chem., 2003, 19, 245. 3¡¢M. C. Sarva, G. Romeo, F. Guerrera, M. Siracusa, L. Salerno, F. Russo, A. Cagnotto, M. Goegan, T. Mennini, Bioorg. Med. Chem., 2001, 10, 313. ÇëÐֵܽãÃÃÃÇ¿´µ½ºó°ïæһÏ£¬¸øÎһظ´£¬¶àл£¡£¡£¡£¡ |
» ²ÂÄãϲ»¶
268Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
302Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
311Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
±»ÎÒÑÔÖУºÐÂÄ£°å²»Ç¿µ÷¸ñʽÁË£¬¼Ùר¼Ò¿ªÊ¼¹Ü¸ñʽÁË
ÒѾÓÐ4È˻ظ´
303Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
¿¼ÑÐÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ
ÒѾÓÐ4È˻ظ´
085601²ÄÁϹ¤³Ìר˶Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸Ìì½ò´óѧ»¯Ñ§¹¤ÒÕרҵ£¨081702£©315·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
ÄÜÔ´²ÄÁÏ»¯Ñ§¿ÎÌâ×éÕÐÊÕ˶ʿÑо¿Éú8-10Ãû
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÇàÄê»ù½ðÖÐÖ÷Òª²Î¿¼ÎÄÏ׺ÍÖ÷ÒªÂÛÖøµÄ¸ñʽҪÇóÒÔ¼°½áÌâÐèÒª¼¸ÆªÂÛÎÄ
ÒѾÓÐ5È˻ظ´
ѡʲôÑùµÄÎÄÕÂ×÷Ϊ²Î¿¼ÎÄÏ׺ã¿
ÒѾÓÐ8È˻ظ´
ÖØ½ðÇóÖú-3ƪ²Î¿¼ÎÄÏ×¶ÔÓ¦µÄÌâÄ¿ÊÇʲô£¿£¿£¿
ÒѾÓÐ5È˻ظ´
¹ØÓÚÂÛÎIJο¼ÎÄÏ×ÖÐÈËÃûµÄд·¨
ÒѾÓÐ6È˻ظ´
ÖÐÎIJο¼ÎÄÏ×ÈçºÎ·Òë
ÒѾÓÐ5È˻ظ´
Ôõô²éÕÒÂÛÎÄÀïÓ¢ÎIJο¼ÎÄÏ׵ľßÌåÄÚÈÝ
ÒѾÓÐ12È˻ظ´
Nanotechnology proof Îļþ µÄ²Î¿¼ÎÄÏײ¿·ÖÓÐЩûÓÐÀ¶É«Á´½ÓµÄÎÊÌâ
ÒѾÓÐ6È˻ظ´
ÎÒµÄÎÄÕÂÐèÒªÒýÓÃһƪ²Î¿¼ÎÄÏ×£¬¿ÉÊÇÕâÆªÎÄÏ×ûÓÐÆðÖ¹Ò³£¬ÔõôעÃ÷ÄØ
ÒѾÓÐ12È˻ظ´
Óйزο¼ÎÄÏ×д·¨µÄСÎÊÌâ
ÒѾÓÐ9È˻ظ´
»áÒéÎÄÕ½ÓÊÜÁ˵«»¹Ã»·¢±í£¬ÈçºÎ½«ÆäÓÃ×ö²Î¿¼ÎÄÏ×£¿
ÒѾÓÐ31È˻ظ´
ÔõÑùËÑË÷±»¶àƪÎÄÏ×¹²Í¬ÒýÓõÄÄÇһƪÎÄÏ×?
ÒѾÓÐ11È˻ظ´
¹ØÓÚÔÚSCIÂÛÎÄÖÐ׫дÖÐÎIJο¼ÎÄÏ×µÄÎÊÌâ
ÒѾÓÐ11È˻ظ´
Çë½ÌÒ»¸öSCI²Î¿¼ÎÄÏ×д·¨µÄÎÊÌâ
ÒѾÓÐ3È˻ظ´
²©Ê¿Ñ§Î»ÂÛÎĵIJο¼ÎÄÏ×Ò»°ã¶àÉÙÆª£¿£¿ 27ƪËãÉÙÂð£¿
ÒѾÓÐ73È˻ظ´
²Î¿¼ÎÄÏ×ÀïµÄÎÄÕÂÔõôËÑË÷£¿
ÒѾÓÐ4È˻ظ´
±ÏÒµÂÛÎIJο¼ÎÄÏ×µÄÕûÀí
ÒѾÓÐ50È˻ظ´
ÎÄÕºóÃæµÄ²Î¿¼ÎÄÏ×£¬ÔÚÎÄÖж¼±ØÐë³öÏÖÂð£¿
ÒѾÓÐ33È˻ظ´
Ó¢ÎÄÂÛÎÄÖеÄÖÐÎIJο¼ÎÄÏ×ÊÇ·ñÐèҪŪ³ÉÓ¢ÓïÄØ£¿
ÒѾÓÐ16È˻ظ´

cxmlxmf123
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7990.9
- É¢½ð: 49
- ºì»¨: 10
- Ìû×Ó: 5197
- ÔÚÏß: 708.8Сʱ
- ³æºÅ: 355544
- ×¢²á: 2007-04-25
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É

4Â¥2011-07-20 11:54:17
winmoon
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 154.5
- É¢½ð: 100
- Ìû×Ó: 74
- ÔÚÏß: 150.7Сʱ
- ³æºÅ: 464188
- ×¢²á: 2007-11-21
- רҵ: ÎÀÉú¶¾Àí
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
sunke(½ð±Ò+1): ¹ÄÀø½»Á÷ 2011-07-20 15:43:31
sunke(½ð±Ò+1): ¹ÄÀø½»Á÷ 2011-07-20 15:43:31
| 1 Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro |
2Â¥2011-07-20 11:47:09
winmoon
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 154.5
- É¢½ð: 100
- Ìû×Ó: 74
- ÔÚÏß: 150.7Сʱ
- ³æºÅ: 464188
- ×¢²á: 2007-11-21
- רҵ: ÎÀÉú¶¾Àí
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
sunke(½ð±Ò+1): ¹ÄÀø½»Á÷ 2011-07-20 15:43:37
sunke(½ð±Ò+1): ¹ÄÀø½»Á÷ 2011-07-20 15:43:37
| 3 [1,2,4]Triazole derivatives as 5-HT(1A) serotonin receptor ligands. |
3Â¥2011-07-20 11:50:35
cxmlxmf123
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 7990.9
- É¢½ð: 49
- ºì»¨: 10
- Ìû×Ó: 5197
- ÔÚÏß: 708.8Сʱ
- ³æºÅ: 355544
- ×¢²á: 2007-04-25
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É

5Â¥2011-07-20 11:55:05













»Ø¸´´ËÂ¥